Is vigabatrin a controlled substance?

Is vigabatrin regulated as a controlled substance?

Vigabatrin is an antiseizure medicine used for certain epilepsy syndromes. It is not generally classified as a “controlled substance” under U.S. federal controlled-substance scheduling (such as Schedules I–V).

That said, requirements for handling, prescribing, dispensing, and monitoring can still be strict because vigabatrin has major safety concerns (notably vision-related side effects) and is typically dispensed only under specific program controls rather than controlled-substance rules.

What kind of monitoring restrictions does vigabatrin have if it’s not scheduled?

Even when a drug is not controlled under controlled-substance schedules, regulators and manufacturers can impose tighter safeguards. For vigabatrin, risk management focuses on minimizing and detecting retinal/visual toxicity through scheduled ophthalmologic monitoring and controlled access processes.

How can I confirm the rule for my country or pharmacy system?

Controlled-substance status depends on the country (and sometimes the specific listing authority within that country). The most reliable checks are:
- Your local drug scheduling database (or national regulator site)
- Your pharmacy’s compliance system
- The prescribing information/labeling for your region

If you tell me your country (and, if relevant, whether you mean U.S. federal or a specific state/province), I can tailor the answer to the exact scheduling authority you’d be dealing with.